dhamptonii wrote:rp1954 wrote:What is her CA199, LDH, HgbA1C hsCRP or ESR ? The more blood data you have, the better you can tune these things.
Do I ask her doctor to requisition these specific levels? I presume they aren't common and I should ask the PA when we go in today for a lab order? She has her 4th treatment today and starts Avastin.
All are commonly available lab panels, but not necessarily for standard econobox monitoring of CRC, typically done with a Chem12 or 14 metabolic panel. My parent 35 years ago got a Chem25 with most of this data for mCRC, so much for clinical progress. CRC researchers will use more panels, Dr Kemany will use more panels for HAI, alternative MDs will use more panels. Extra cancer markers ( and "distant panels") are where the fights usually start - it is often easiest to just pay for the first set of some panels then insist on monitoring anomalies (you might have to add or change drs).
How did you get the lab tissue results? Is that something I can ask for? Would they be in the genetics report I just got?
CA199 and/or CSLEX1 immunohistochemistry in your current reports, no. The pathologists are typically resistant to less standard or outside requests without a known requesting dr with enough stroke. I went to a private university for a number of markers on a research basis and made a generous contribution; this was slow and not consumer friendly. One CT person here got their CA199 tissue done for immunohistochemistry by their doctor because their peak CEA before surgery was too low to monitor effectively, and CA199 was likely a marker because of Kras mutant. Good insurance paid, too.
This is an area that needs to reworked so others can get real pathology service on tumor tissue for CA199+CSLEX1. The payoffs would be targetable, perioperative chemo during the 6 week gaps around surgery and targetable, mild cleanup/maintenance chemo options longer term.